Efficacy of Omalizumab, Dupilumab, and Remibrutinib in Chronic Spontaneous Urticaria: Phase Data and Placebo Response.
Allergy, 2025 (SCI-Expanded, Scopus)
- Publication Type: Article / Letter
- Volume:
- Publication Date: 2025
- Doi Number: 10.1111/all.16670
- Journal Name: Allergy
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, Food Science & Technology Abstracts, Veterinary Science Database
- Erciyes University Affiliated: Yes